COMP <GO>
RNAC vs AKBA // EV/EBITDA & P/E VALUATION
Cartesian Therapeutics Inc. (NASDAQ) VS. Akebia Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: RNAC 0
— AKBA 7
■ METRIC PARITY
LAST: $6.49 (-3.85%) • MKT CAP: $204.2M
valuation
—
LAST: $0.71 (-4.81%) • MKT CAP: $205.7M
valuation
4.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RNAC VS. AKBA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RNAC | AKBA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 83.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 85.00% | -120.00 | AKBA | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 4.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | 9.90% | -69.90 | AKBA | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -2.20% | -57.80 | AKBA | /net-margins <GO> |
| Revenue Growth (YoY) | -65.00% | 47.50% | -112.50 | AKBA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 0.20 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 7/9 | -5.00 | AKBA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.7 | 45.2 | -5.55 | AKBA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $204.2M | $205.7M | -$1.4M | AKBA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RNAC REV | AKBA REV | RNAC GROSS % | AKBA GROSS % | RNAC FCF | AKBA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $400.0K | $236.2M | — | 83.3% | -$79.4M | $67.7M |
| FY 2024 | $38.3M | $160.2M | — | 60.6% | -$32.8M | -$40.7M |
| FY 2023 | $26.0M | $194.6M | — | — | -$51.2M | -$23.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RNAC // BETA —
AKBA // BETA —